FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape Read more
Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart Read more
AstraZeneca Pharma India gains CDSCO approval for treating endometrial cancer in the country Read more